Cargando…
Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
The advent of new medications and new treatment strategies for rheumatoid arthritis has made it possible to achieve remission in more patients than before. Furthermore, recent clinical trials and register studies suggest that some patients who initially required aggressive therapy may achieve biolog...
Autores principales: | Nagy, György, van Vollenhoven, Ronald F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522973/ https://www.ncbi.nlm.nih.gov/pubmed/26235544 http://dx.doi.org/10.1186/s13075-015-0707-1 |
Ejemplares similares
-
The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
por: Smolen, Josef S, et al.
Publicado: (2008) -
Synovial fibroblasts as potential drug targets in rheumatoid arthritis, where do we stand and where shall we go?
por: Németh, Tamás, et al.
Publicado: (2022) -
Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
por: Burkard, Theresa, et al.
Publicado: (2021) -
Drug-free remission: the goal of the future in management of patients with rheumatoid arthritis
por: Filipowicz-Sosnowska, Anna
Publicado: (2017) -
Biologic-free remission by orthopaedic surgery in non-responder to infliximab for rheumatoid arthritis
por: Kanbe, Katsuaki, et al.
Publicado: (2015)